Zepbound tirzepatide injection: the US brand that doesn't exist in the UK

Is Zepbound the same injection as Mounjaro?

Yes, in every meaningful clinical sense. Zepbound and Mounjaro share the same active ingredient (tirzepatide), the same mechanism, and the same pen delivery format. Eli Lilly chose different brand names for different markets: Mounjaro reached the US first as a diabetes treatment, then Zepbound launched there for weight management. In the UK, Eli Lilly received a single licence covering both indications under the Mounjaro name, so the Zepbound branding simply never applied here.

This matters if you've read about Zepbound in US media or seen it mentioned in weight-loss forums. Trial data, dosing schedules and side-effect profiles described for Zepbound overseas translate directly to Mounjaro in the UK, the molecules are identical. US pricing and US dosing pen presentations, however, do not apply, and any seller offering "Zepbound" to UK customers should be treated as a serious red flag. The MHRA has warned publicly about counterfeit weight-loss pens sold through social media and unlicensed channels, and in 2025 enforcement agencies seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. If a source is offering a product under the Zepbound name in the UK, it is not from the licensed UK supply chain.

For a clear overview of how tirzepatide is licensed and used here, the tirzepatide injection guide covers the UK picture in full.

How does the tirzepatide injection actually work in the body?

Tirzepatide is a dual receptor agonist, it binds to receptors for two gut hormones, GIP and GLP-1, that are released naturally when you eat. Activating both pathways at once signals to the brain that the body has had enough food, slows the rate at which the stomach empties, and helps regulate blood sugar. The practical result for most people is a meaningful, sustained reduction in appetite.

The injection itself is a once-weekly subcutaneous dose given just under the skin at the abdomen, thigh, or upper arm. Each Mounjaro KwikPen contains four weekly doses. A needle is attached before each use, the skin cleaned, the pen pressed against the injection site, and the button pressed to deliver the dose. Rotating sites from week to week reduces the chance of local reactions. If you're new to the process, the step-by-step detail in our guide to how to inject tirzepatide walks through technique clearly.

The most common side effects follow the GI pattern you'd expect from slowing gastric emptying: nausea, constipation, diarrhoea, indigestion, and occasional burping or reflux. These are typically most noticeable in the first week or two at each new dose level and settle for most people as the body adjusts. Severe, persistent stomach pain that spreads to the back warrants urgent medical attention, as the MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 class medicines, report any suspected side effects via the Yellow Card scheme.

Which weight-loss injections are actually licensed in the UK?

Two injectable medicines are currently licensed in the UK specifically for weight management in adults: Mounjaro (tirzepatide) and Wegovy (semaglutide). Both require a prescription following clinical assessment. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related health condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. NICE recommends tirzepatide under TA1026 for eligible adults, and the NHS is rolling out access in phases, but NHS waiting lists can be long, and criteria at this stage remain strict.

Private treatment through a regulated online pharmacy is the alternative for people who don't meet the current NHS thresholds or don't want to wait. The Mounjaro overview covers eligibility and what private treatment involves. If cost is on your mind, the honest breakdown of Mounjaro costs in the UK explains what private prices typically include, and why the cheapest listing is often the wrong measure for a prescription medicine. To explore all available licensed treatment options, our weight-loss treatment overview gives the full picture.

Ozempic is also semaglutide, but it holds a UK licence for type 2 diabetes rather than weight loss, so it sits in a different category entirely. Saxenda (liraglutide) is licensed for weight management but not dispensed by nume. Zepbound, as covered above, does not exist as a UK product.

What does a Mounjaro order through a regulated UK pharmacy actually look like?

Once a prescriber approves treatment, the pen is dispatched the same day (for orders placed before 12pm, Monday to Friday) via DPD. You'll get a tracking link to your phone, and the parcel arrives the next working day in plain, unbranded packaging, nothing on the outside to indicate what's inside. The KwikPen itself is a compact, pre-filled device; each contains your four weekly doses, and needles are attached fresh for each injection.

The Mounjaro KwikPen guide explains the device's parts and how to handle it, and needle selection for tirzepatide covers the gauge and length questions that come up most often. Used needles and pens go into a sharps container (never into household recycling) and a 1-litre sharps bin is the right size for most people on this treatment.

Clinical oversight doesn't end at dispatch. Every repeat order is reviewed by a prescriber before it goes out, and aftercare support is available seven days a week. If you'd like to find out whether tirzepatide treatment is suitable for you, speak to our prescribers through a free consultation, a real clinician reads your answers the same day, not a queue for automated software. You can read more about our clinical team on our prescriber profile page.